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Introduction
In all species studied, the regulation of the meiotic cell cycle is 
orchestrated by maturation-promoting factor (MPF), a complex 
of the Cdc2/cdk1 kinase and the regulatory cyclin B. Activation 
of the Cdc2 kinase requires the association with cyclins as well 
as the dephosphorylation of Thr 14 and Tyr 15 residues (Nurse, 
1990; Morgan, 1995). The phosphorylation state of these two 
critical residues on Cdc2 is dictated by a balance between the 
activity of the Wee1 kinases and the Cdc25 phosphatases (Lew 
and Kornbluth, 1996). In mouse oocytes, genetic studies have 
established that Cdc25B rather than Cdc25C, as in frogs, is criti-
cal for meiotic reentry (Kumagai and Dunphy, 1992; Lincoln 
et al., 2002); conversely, several Wee kinases, including the 
somatic Wee1, Myt1, and, more recently, the embryonic Wee1B 
(Wee2), have been implicated in meiotic arrest (Mitra and 
Schultz, 1996; Kanatsu-Shinohara et al., 2000; Okumura et al., 
2002; Han et al., 2005). In both mitosis and meiosis, after an ini-
tial activation in discrete cytoplasmic compartments, the Cdc2–
cyclin B complex enters the nucleus to phosphorylate specific 
targets required for germinal vesicle (GV) breakdown (GVBD), 
the hallmark of the prophase to metaphase transition (Ookata 
et al., 1992; Mitra and Schultz, 1996; Marangos and Carroll, 
2004). Thus, the local activation and translocation of MPF is an 
important event for prophase to anaphase transition. Although 
MPF translocation to the oocyte’s nucleus has been described 
(Mitra and Schultz, 1996; Marangos and Carroll, 2004), the sub-
cellular localization of regulatory kinases and phosphatase has 
not been extensively explored in mammalian oocytes.
Results and discussion
Cooperative functions of Wee1B with Myt1 
in maintaining meiotic arrest
We previously reported that down-regulation of the maternal 
Wee1B mRNA causes resumption of meiosis of mouse oocytes 
(Han et al., 2005), implicating this kinase in the maintenance 
of meiotic arrest. Because only a portion of the oocytes resumed 
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kinases and Cdc25 phosphatases. In this study, we demon-
strate that the sequestration of components that regulate 
MPF activity in distinct subcellular compartments is essential 
for their function during meiosis. Down-regulation of either 
Wee1B or Myt1 causes partial meiotic resumption, and 
oocytes reenter the cell cycle only when both proteins are 
down-regulated. Shortly before GV breakdown (GVBD), 
Cdc25B is translocated from the cytoplasm to the nucleus, 
whereas Wee1B is exported from the nucleus to the cyto-
plasm. These movements are regulated by PKA inactivation 
and MPF activation, respectively. Mislocalized Wee1B or 
Myt1 is not able to maintain meiotic arrest. Thus, coopera-
tion of Wee1B, Myt1, and Cdc25 is required to maintain 
meiotic arrest and relocation of these components before 
GVBD is necessary for meiotic reentry.
Wee1B, Myt1, and Cdc25 function in distinct 
compartments of the mouse oocyte to control 
meiotic resumption
Jeong Su Oh,1 Seung Jin Han,2 and Marco Conti1
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Center for Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143
2School of Biological Sciences, College of Biomedical Science and Engineering, Inje University, Gimhae, Gyeongnam 621-749, Korea
© 2010 Oh et al. This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date (see 
http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative 
























JCB • VOLUME 188 • NUMBER 2 • 2010 200
confirmed by down-regulation of recombinant protein ex-
pression in frog and mouse oocytes and by a rescue experi-
ment (Fig. S1).
Dynamic localization of MPF regulators
Because both Myt1 and Wee1B are required to stabilize the 
GV state, we next asked why two kinases with overlapping 
functions are necessary to maintain meiotic arrest. An expla-
nation for this redundancy is that the two kinases are confined 
to different compartments within the oocyte. To test this pos-
sibility, we microinjected Wee1B and Myt1 as well as the 
phosphatase Cdc25B tagged with GFP, YFP, and RFP, respec-
tively, into GV oocytes (Fig. 2 A). It should be noted that all 
three proteins were rendered catalytically inactive to avoid 
confounding effects on oocyte maturation. In GV oocytes, 
GFP-Wee1B was entirely confined to the nucleus, whereas 
YFP-Myt1 was excluded from the nucleus and distributed in a 
punctate pattern in the cytoplasm. This localization was con-
firmed and further resolved by scanning confocal microscopy 
(Fig. S2). In contrast, RFP-Cdc25B was localized mainly in 
the cytoplasm of GV oocytes. Identical localization of the 
three proteins was observed when these constructs were used 
in the transfection of somatic cells (unpublished data). More-
over, the localization was independent of the amount of re-
combinant protein expressed and of the tag used to detect the 
expressed proteins (unpublished data).
Under conditions that allow meiotic resumption, a signifi-
cant fraction of Wee1B was translocated to the cytoplasm shortly 
before GVBD at a time when Cdc25B had entered the nucleus 
(Fig. 2 A). In contrast, the localization of Myt1 did not change 
during meiotic resumption. After GVBD, both Wee1B and 
Cdc25B were distributed throughout the entire oocyte intracellular 
meiosis, we hypothesized that this incomplete phenotype 
is caused by compensation of the loss of Wee1B activity 
by Myt1 and/or the somatic Wee1 (termed in this study 
Wee1A). To investigate the relative contribution of the three 
kinases in imposing the meiotic arrest, we designed morpho-
lino oligonucleotides (MOs) corresponding to Wee1A, Myt1, 
and Wee1B by overlapping the initiator ATG of each mRNA. 
Less than 10% GVBD was induced with the injection of 
Wee1A MO, a value comparable with scrambled control MO 
(Fig. 1 A), indicating that this kinase is not involved in enforc-
ing the meiotic arrest. This conclusion is consistent with the 
low mRNA levels for Wee1A detected in mature oocytes (Han 
et al., 2005). In contrast, 35% of the oocytes underwent GVBD 
after injection of Wee1B MO, which is a result consistent with 
our previous experiments (Han et al., 2005). Down-regulation 
of Myt1 also induced GVBD by 22% (Fig. 1 A). Only com-
bined down-regulation of Wee1B and Myt1 produced GVBD 
in the majority of the oocytes (Fig. 1 A). Similar results were 
obtained in pde3a-null oocytes, which are permanently ar-
rested in GV stage because of high cAMP and PKA activity 
(Fig. 1 B). These results indicate that Wee1B and Myt1 but not 
Wee1A cooperate in maintaining the meiotic arrest in mouse 
oocytes. The presence of a fraction of oocytes that do not re-
enter meiosis after combined MO injection is likely caused by 
the incomplete knockdown of these proteins. Available anti-
bodies do not detect the endogenous Myt1 and Wee1B in 
immunocytochemistry, and a large number of oocytes are re-
quired to obtain a significant signal in Western blot analysis, 
rendering technically difficult the detection of endogenous 
proteins in injected oocytes. Therefore, it has not been possible to 
directly monitor the efficiency of the MO down-regulation. 
Nevertheless, the specificity and efficacy of each MO was 
Figure 1. Effect of down-regulation of Wee1 kinases on mouse oocyte meiotic arrest. (A and B) WT (A) or pde3a/ (B) oocytes were injected with MO 
corresponding to Wee1A, Wee1B, or Myt1. Scrambled MO (Ctrl) was used as a negative control. Error bars indicate SEM. Numbers above the bars 
indicate the number of oocytes in the GVBD stage and number of total oocytes, respectively, as well as the number of experiments performed. *, P < 0.005; 
and **, P < 0.0001 compared with control. ***, P = 0.0192.
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reject this possibility. Staining of the nuclear lamina with anti–
lamin A antibody showed that the nuclear envelope was still 
intact when GFP-Wee1B was detected in both the nucleus and 
cytoplasm (Fig. 2 B). Furthermore, nuclear injected 70-kD dextran, 
with size comparable with GFP-Wee1B and excluded by the nu-
clear pores, was still retained in the nucleus at a time when signifi-
cant amounts of Wee1B accumulated in the cytoplasm (Fig. 2 C). 
These results strongly suggest that Wee1B is actively exported 
from the nucleus rather than being subjected to passive redistribu-
tion with the breakdown of the nuclear membrane at GVBD.
Nucleocytoplasmic shuttling of Wee1B is 
mediated by NLS and nuclear export signal 
(NES) sequences
Because Wee1B is found in both the cytoplasm and nucleus de-
pending on the stage of maturation, it must encode mechanisms 
space. A detailed time course analysis comparing Cdc25B import 
and Wee1B export from the nucleus showed that Cdc25B entry 
preceded Wee1B extrusion (Fig. S3 and Videos 1–3). Wee1B 
export occurs at a time that roughly coincides with the timing of 
Cdc2–cyclin B translocation to the nucleus (15–20 min before 
GVBD; Marangos and Carroll, 2004). It has been previously 
shown that Swe1, a yeast homologue of Wee1, shuttles between 
the nucleus and cytoplasm during the mitotic cell cycle (Longtine 
et al., 2000; Keaton et al., 2008) and that the nuclear shuttling of 
Cdc25B accompanies meiotic resumption (Solc et al., 2008; 
Zhang et al., 2008; Pirino et al., 2009). Thus, our data are consis-
tent with these previous observations in the mitotic cell cycle.
Because the nuclear export occurred just before GVBD, we 
investigated whether the accumulation of GFP-Wee1B fluores-
cence in the cytoplasm is simply the result of passive diffusion 
during the breakdown of the nuclear envelope. Two experiments 
Figure 2. Localization of Wee1B, Myt1, and Cdc25B during meiotic resumption. (A) Subcellular localization of Wee1B, Myt1, and Cdc25B was monitored 
by imaging live cells during meiotic resumption. (B) GFP-Wee1B–injected GV oocytes were stained with anti–lamin A antibody during the course of Wee1B 
export. (C) Oocyte nuclei were injected with 70 kD of Texas red–labeled dextran, and fluorescence was monitored during the export of GFP-Wee1B. 
DIC, differential interference contrast. Bars: (A and C) 20 µm; (B) 60 µm.
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Nuclear export of NES-containing proteins is dependent 
on interactions with the Crm1 nuclear export receptor, which 
is located on the nuclear envelope (Sorokin et al., 2007). To 
determine whether Wee1B binds to Crm1 in vivo, we per-
formed an immunoprecipitation assay in which WT and mutant 
Wee1B were expressed in a heterologous system. Wee1B-WT 
and Wee1B-NLS coprecipitated with Crm1, whereas little 
immunoprecipitate was observed with Wee1B-NESmut and 
Wee1B-NLS/NESmut (Fig. 3 C). Together with the localiza-
tion data, these findings document that Wee1B binds to Crm1 
through the identified NES sequence and point mutations in this 
region disrupt this interaction.
Different signaling pathways are involved in 
Cdc25B and Wee1B translocation
Because MPF regulates the activities of Wee1 and Cdc25 
by positive and negative feedback mechanisms (Perry and 
Kornbluth, 2007; Ferrell, 2008), we investigated whether the 
nucleocytoplasmic shuttling of Wee1B or Cdc25B is under the 
control of this cell cycle regulator. GFP-Wee1B or RFP-Cdc25B 
was microinjected into GV oocytes and incubated with or with-
out the Cdc2 inhibitor roscovitine. This inhibition of MPF com-
pletely blocked Wee1B export but had no effect on the nuclear 
import of Cdc25B (Fig. 4 A).
Given that Wee1B and Cdc25B are both substrates of 
PKA (Han et al., 2005; Han and Conti, 2006; Zhang et al., 2008; 
Pirino et al., 2009; Schultz, 2009), it is possible that Wee1B or 
Cdc25B phosphorylation by PKA controls their subcellular 
localization. Whereas point mutations of a putative PKA site 
on Wee1B (Ser 15 and Thr 170 residues) did not affect its sub-
cellular localization (not depicted), a PKA regulatory role in 
the localization of Cdc25B was supported by the mutation of 
Ser 321 residue, which promoted the nuclear import of Cdc25B 
(Fig. 4 B). Moreover, this Cdc25B Ser 321 mutant was more 
 effective in inducing GVBD than WT control (Fig. 4 C), and 
this mutation affected Cdc25B association with a 14-3-3 (Fig. 4, 
D and E). Finally, using pde3a/ oocytes, we show that PKA 
inhibition caused prompt nuclear translocation of the injected 
RFP-Cdc25B (Fig. 4 F). These findings are consistent with data 
published while this paper was in preparation demonstrating 
that Cdc25B Ser 321 phosphorylation by PKA negatively regu-
lates Cdc25B by preventing its nuclear accumulation (Zhang 
et al., 2008; Pirino et al., 2009; Schultz, 2009). These results 
also indicate that the mechanisms activating nuclear import 
of Cdc25B precede and are upstream of the control of Wee1B 
export. Indeed, nuclear import of Cdc25B occurs before Wee1B 
export during meiotic resumption (Fig. S3 and Videos 1–3). 
Collectively, these results suggest that this reciprocal transloca-
tion of the enzymes is an important event for the regulation 
of nuclear MPF and for meiotic resumption.
Correct localization is necessary for the 
proper function of Wee1B and Myt1
To investigate the functional significance of Wee1B export from 
the nucleus, we determined the biological activity of a cytoplasmic 
Wee1B. Active Wee1B-targeting mutants were microinjected 
into GV-arrested oocytes, and meiotic resumption was determined 
for nucleocytoplasmic shuttling. NLS and NES sequences 
often mediate protein transport between the nucleus and 
cytoplasm (Sorokin et al., 2007). Thus, we analyzed the 
amino acid sequence of Wee1B and identified putative NLS 
and NES sequences in the regulatory N-terminal domain 
and catalytic domain of Wee1B, respectively (Fig. 3 A). 
To confirm the functionality of these putative NLS and NES 
sequences in nucleocytoplasmic shuttling of Wee1B during 
meiotic resumption, we generated an NLS deletion mutant 
(Wee1B-NLS), an NES mutant in which critical hydrophobic 
amino acid residues were replaced by Ala residues (Wee1B-
NESmut), and an NLS and NES double mutant (Wee1B-NLS/
NESmut). In GV oocytes, Wee1B wild type (WT; Wee1B- 
WT) and Wee1B-NESmut were confined to the nucleus, 
whereas Wee1B-NLS exhibited cytoplasmic localization. 
Wee1B-NLS/NESmut was found in the nucleus as well as in 
the cytoplasm (Fig. 3 B).
Figure 3. Nucleocytoplasmic shuttling of Wee1B is mediated by NLS 
and NES. (A) Schematic representation of the structure of Wee1B. 
The catalytic domain is shaded. The potential NLS sequence is indi-
cated by a blue bar and aligned with human homologues. The putative 
NES sequence is indicated by a red bar and shown with the other 
known NES sequences. The consensus sequences of NLS and NES 
are shown in bold. The numbers above the structure refer to the amino 
acids of Wee1B. (B) Localization of Wee1B-targeting mutants was shown 
with representative brightfield and fluorescence images. (C) Immuno-
precipitation (IP) of Wee1B-targeting mutants and Crm1. WB, Western 
blot. Bar, 20 µm.
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(Rothblum-Oviatt et al., 2001; Katayama et al., 2005; Kim 
et al., 2005; Okamoto and Sagata, 2007). In the same vein, it has 
been previously shown that nuclear export of Swe1 is required 
for its destruction (Keaton et al., 2008). However, the mouse 
Wee1B protein is resistant to degradation in frog oocytes even 
when Cdc2 is maximally activated, rendering it less likely 
that degradation is a mechanism of Wee1B inactivation during 
mammalian prophase to metaphase transition. Thus, one can 
hypothesize that the nuclear export of Wee1B, likely dependent 
on nuclear Cdc2 activity, may either promote the inactivation of 
this kinase or prevent its access to substrate MPF. The data 
showing greatly reduced ability of cytoplasmic Wee1B to block 
maturation are consistent with this hypothesis. At variance with 
most proteins containing NES sequences, we found that Wee1B 
has an NES sequence within the catalytic domain. This raises 
the interesting possibility that the binding of nuclear export pro-
teins to the NES may have a role not only in nuclear export but 
also in the modulation of the kinase activity by masking the 
Wee1B catalytic domain. Alternatively and after the nuclear 
import of Cdc25B, Cdc2 activation may cause phosphorylation 
and inactivation of Wee1B, and the associated conformational 
change allows Crm1 access to the Wee1B NES and export of 
the protein to the cytoplasm.
by scoring GVBD. Microinjection of nuclear Wee1B proteins 
(Wee1B-WT and Wee1B-NESmut) led to an efficient and com-
plete block of meiotic resumption, whereas cytoplasmic Wee1B 
mutants (Wee1B-NLS and Wee1B-NLS/NESmut) failed to 
block maturation (Fig. 5 A). It is noteworthy that the level 
of protein expression was comparable for the different Wee1B 
mutants and that the activity of different Wee1B constructs 
measured by their effects on Cdc2-dependent histone H1 phos-
phorylation was not significantly different (Fig. 5 B). These 
results confirm that the inability of cytoplasmic Wee1B to block 
MPF activity is not simply caused by decreased activity associ-
ated with the disruption of the NLS or NES sequences but rather 
results from mislocalization of the mutant protein. Proper local-
ization of Myt1 is also important for its function. Indeed, Myt1 
chimeric proteins containing a C-terminal NLS sequence from 
SV40 large T antigen (Myt1-NLS) were designed, and appropriate 
nuclear expression of this Myt1 mutant by microinjection in GV 
oocytes was verified (Fig. 5 C). Microinjection of Myt1-NLS 
blocked GVBD less efficiently than WT (Myt1-WT; Fig. 5 D).
Because Wee1B is a Cdc2 inhibitor, it must be inactivated 
during M-phase progression. Several mechanisms of Wee1 
inactivation have been identified, including phosphorylation 
and degradation as well as binding to other regulatory proteins 
Figure 4. Regulation of subcellular localization of Wee1B and Cdc25B. (A) RFP-Cdc25B– or GFP-Wee1B mRNA–injected oocytes were incubated with or 
without 50 µM roscovitine for 1 h. The arrow indicates a GV oocyte in which Wee1B is exported from the nucleus. (B) Subcellular localization of Ser 321 
mutants of Cdc25B. (C) WT or S321A mutant Cdc25B mRNAs were injected into Xenopus oocytes, and the percentage of GVBD was determined after 
6 h. The amounts of injected mRNAs were compared by immunoblot analysis. (D) The Ser 321 PKA phosphorylation site is overlapped with the 14-3-3 
binding site. Identical and conserved residues are shaded in black and gray, respectively. (E) Immunoprecipitation of Cdc25B mutants and 14-3-3. Black 
lines indicate that intervening lanes have been spliced out. (F) RFP-Cdc25B was injected into pde3a/ oocytes and incubated with or without 50 µM H89 
for 2 h, and localization of fusion proteins was shown. Bars: (A) 60 µm; (B and F) 20 µm.
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case, overexpression of Wee1B would completely prevent the 
activation of MPF in the nucleus, which is a prerequisite for 
the induction of meiotic resumption, whereas Myt1, although 
able to inactivate MPF in the cytoplasm, cannot block the acti-
vation of the MPF localized in the nucleus. It is well docu-
mented that MPF relocation to the nucleus is closely related to 
GVBD during meiotic maturation of the oocytes (Ookata 
et al., 1992; Mitra and Schultz, 1996). Collectively, these re-
sults provide evidence that the efficient maintenance of meiotic 
We observed that overexpressed Myt1-WT inhibited 
GVBD less effectively than Wee1B (Fig. 5, A and D; and 
Fig. S1, A and E), even though Myt1 was previously identified 
as a Cdc2 inhibitor (Mueller et al., 1995; Fattaey and Booher, 
1997). In agreement with our results, it has been reported that 
the inhibitory activity of XeMyt1 is also weaker than that of 
Wee1 in Xenopus laevis oocytes (Okamoto et al., 2002). It is 
likely that small amounts of MPF in immature oocytes contin-
uously shuttle between the nucleus and cytoplasm. In this 
Figure 5. Localization and function of Wee1 kinases in meiotic arrest. (A and D) Oocytes were injected with the indicated Wee1B (A) or Myt1 (D) mRNAs, 
washed out of the inhibitor, and monitored for the absence of a GV (GVBD). These experiments were repeated three times, and the error bars indicate 
SEM. The expression levels of injected mRNAs were compared by immunoblotting with the GFP antibody. (B) The activity of Wee1B-targeting mutants was 
measured by H1 kinase assay. The data are representative of three independent experiments. The ratio of 32P incorporation into histone H1 and the amount 
of immunocomplexes were densitometrically measured and represented as a mean percentage ± SEM of control (Mock). (C) Localization of WT and NLS 
mutants of Myt1 was shown with brightfield and fluorescence images. Bar, 20 µm.
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48 h apart. Ovulated oocytes were released from the ampullae of oviducts 
16 h after human chorionic gonadotrophin. The cumulus cells were dis-
persed by brief exposure to 0.1 M hyaluronidase.
The activity of Wee1B kinase was determined with five randomly 
selected metaphase II–arrested oocytes. H1 kinase assay was performed as 
previously described (Svoboda et al., 2001). In brief, various GFP-Wee1B–
targeting mutants were transiently transfected into HEK293 cells, and over-
expressed Wee1B proteins were immunoprecipitated with V5 antibodies 
(Invitrogen). Oocytes were lysed in 5 µl of lysis buffer (10 µg/ml aprotinin, 
10 µg/ml leupeptin, 10 mM p-nitrophenyl phosphate, 20 mM -glycero-
phosphate, 0.1 mM Na orthovanadate, and 5 mM EGTA) and preincu-
bated with Wee1B immunoprecipitates for 20 min. The kinase reaction 
was initiated by the addition of 5 µl of kinase buffer (24 mM p-nitrophenyl 
phosphate, 90 mM -glycerophosphate, 24 mM MgCl2, 24 mM EGTA, 
0.2 mM EDTA, 4.6 mM Na orthovanadate, 4 mM NaF, 1.6 mM DTT, 
60 µg/ml aprotinin, 60 µg/ml leupeptin, 2.2 µM cAMP-dependent protein 
kinase inhibitor, 0.6 mM ATP, and 2 mg/ml histone [type III-S; Sigma-
 Aldrich] with 500 µCi/ml -[32P]ATP [3000 Ci/mmol; GE Healthcare]). 
The reaction was conducted for 30 min at 30°C and terminated by the 
addition of 10 µl of 2× SDS sample buffer and boiling for 3 min. After 
SDS-PAGE, the gel was transferred to a polyvinylidene fluoride membrane 
and analyzed by autoradiography. The membrane was immunoblotted 
with V5 antibodies (Invitrogen).
Plasmids and site-directed mutagenesis
The full-length cDNAs encoding the mouse Wee1B, Myt1, and Cdc25B 
were subcloned into the pcDNA3.1/V5-His-TOPO vector (Invitrogen) as 
previously described (Han et al., 2005). The coding sequences for GFP, 
YFP, and RFP were excised from the vector pEGFP-N1, pYFP-N1, and 
pDsRed-N1 (Takara Bio Inc.), respectively, and inserted in frame at the 3 
end of the Wee1B, Myt1, and Cdc25B sequences to produce the GFP-
Wee1B, YFP-Myt1, and RFP-Cdc25B, respectively. The catalytically inac-
tive mutants of Wee1B (K237M), Myt1 (N229A), and Cdc25B (C483S) 
were generated using site-directed mutagenesis. Wee1B mutants were 
generated using the QuikChange Site-Directed Mutagenesis kit (Agilent 
Technologies) using the following primers: Wee1B-NLS, 5-CCTTCA-
ATCAAAGGGCACCAGAGACTATCTTG-3; and Wee1B-NESmut, 5-CTGCA-
GATTTCCGCCGGAGCTAAGTACATCCAC-3. To generate Myt1-NLS-
mutant, SV40 large T antigen NLS sequence was inserted between Myt1 and 
YFP sequence using PCR-based site-directed mutagenesis with the primer 
5-GGACTCCCTAGACCCACCAAAAAAGAAGAGAAAGGTAGCCTGGG-
CACAGGCC-3. The Crm1 cDNA in pCMV-SPORT6 vector was obtained 
from Thermo Fisher Scientific. To create HA-tagged Crm1, the sequence 
encoding the HA tag was introduced immediately upstream of the initiation 
start codon of Crm1 cDNA. All constructs were sequenced to verify the 
correct insertion and mutation.
In vitro mRNA production for microinjection
mRNAs for microinjection were produced by in vitro transcription using 
mMESSAGE mMACHINE (Applied Biosystems). After in vitro transcription, 
mRNAs were immediately polyadenylated using Poly(A) Tailing kit (Applied 
Biosystems) and purified with RNeasy kit (QIAGEN). The concentration of 
mRNAs was determined by OD260 and agarose gel electrophoresis.
Microinjection and imaging
In vitro transcribed mRNAs were microinjected into the cytoplasm of GV 
oocytes in M2 medium with 4 mg/ml BSA and 5 µM cilostamide using a 
micropipette and Eppendorf manipulators mounted on an inverted micro-
scope (DMI 4000B; Leica). Approximately 10 pl of the mRNA solution con-
taining 250 ng/µl was injected per oocyte. For dextran, oocytes were 
microinjected with Texas red–labeled 70-kD dextran (Invitrogen) dissolved 
at 2.5 µg/ml in PBS into the nucleus. After microinjection, oocytes were 
further incubated at 37°C in 5% CO2 until distinct fluorescent signal was 
detected. For meiotic resumption, oocytes were washed extensively in 
cilostamide-free medium and cultured at 37°C in 5% CO2, and GVBD was 
scored every 30 min for up to 5 h. The microinjected oocytes were observed 
and imaged live on the DMI 4000B inverted microscope. Subgroups of 
microinjected oocytes were used for immunoblotting with anti-GFP antibody 
(Abcam) to confirm the expression of protein. All images were acquired 
using a DMI 4000B inverted microscope, a charge-coupled device camera 
(Retiga 2000R; QImaging) and a 20× NA 0.4 objective lens (Leica). All 
live cell imaging was performed in M2 medium at 37°C. Confocal sections 
of DAPI, GFP, and YFP staining were performed on a confocal micro-
scope (SP5; Leica). Laser beams of wavelengths 360/40, 480/40, and 546/ 
12 nm were used to excite DAPI, GFP, and RFP or Texas red, respectively. 
arrest requires the localization of Wee1B in the nucleus and 
Myt1 in the cytoplasm.
Our data support the concept that the compartmentalization 
of kinases and phosphatases regulating MPF is critical for the 
control of mouse oocyte meiotic arrest and reentry into the cell 
cycle. Wee1B and Myt1 cooperate to maintain meiotic arrest in 
mouse oocytes, whereas the somatic Wee1 is not involved. The 
two kinases act in two distinct subcellular compartments of the 
oocyte. The subcellular localization of Wee1B is dependent on 
the presence of NLS and NES motifs, implying active processes 
of sequestration. Targeting of the enzyme to the cytosol precludes 
its cytostatic function. Different signaling pathways determine 
the localization of Cdc25B and Wee1B in the nuclear and 
cytoplasmic compartments. Whereas the Cdc25B cytoplasmic 
localization is dependent on PKA phosphorylation, the nuclear 
localization of Wee1B does not require PKA regulation. Myt1 
localization is static, but Cdc25 and Wee1B undergo reciprocal 
translocation before GVBD. Cdc25 entry into the nucleus is 
dependent on a decrease in cAMP and PKA, whereas Wee1B 
export is dependent on Cdc2 activation. It is at present unknown 
whether Myt1 activity is constitutive or regulated in a cAMP-
dependent manner in the quiescent state or before the reentry 
into the cell cycle, a possibility which needs to be clarified by 
further experimentation.
Collectively, the aforementioned findings can be accom-
modated in the following working model. A decrease in oocyte 
cAMP and inactivation of PKA causes a rapid and progressive 
Cdc25B translocation to the nucleus, at least initially in the 
absence of changes in MPF activity. The accumulation of the 
phosphatase in the nucleus causes dephosphorylation and acti-
vation of the fraction of MPF that is shuttling into the nucleus. 
In this compartment, the activated MPF promotes the export of 
Wee1B to the cytoplasm through indirect or direct mechanisms. 
This Wee1B translocation functions as an amplification step to 
promote further activation of the nuclear MPF until a threshold 
of activity sufficient for nuclear envelope breakdown is reached. 
Thus, our findings provide a novel mode of Wee1B regulation 
that involves its subcellular relocation at the prophase to meta-
phase transition. The most straightforward and simple conse-
quence of this transfer is that Wee1B no longer has access to its 
MPF substrate and that this is sufficient to cause MPF activa-
tion. However, it is also possible that Wee1B becomes inacti-
vated during the export process or during its accumulation in 
the cytoplasm, further suppressing its cytostatic activity.
Materials and methods
Collection and culture of mouse oocytes and H1 kinase assay
GV oocytes were recovered from the ovaries of 21–24-d-old mice that had 
been administered 5 IU pregnant mare’s serum gonadotropin (PMSG) 
46–48 h earlier. Ovaries were punctured with a fine needle to release 
 oocytes into M2 medium supplemented with 4 mg/ml BSA and 5 µM cilo-
stamide to prevent GVBD. Only oocytes with an intact layer of cumulus 
cells were recovered, and cumulus cells were subsequently removed by 
repeated pipetting with a mouth-operated micropipette. Denuded oocytes 
were then placed in drops of media under oil and cultured at 37°C in 5% 
CO2 atmosphere.
Metaphase II–arrested oocytes were recovered from mice super-
ovulated by i.p. injections of PMSG and human chorionic gonadotrophin 
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Emission was collected at 470/40 nm for DAPI, 527/30 nm for GFP, and 
600/40 nm for RFP or Texas red. Image analysis was performed using 
either QCapture Pro imaging software (QImaging) or Photoshop (Adobe). 
Time-lapse images were acquired by using an inverted microscope (DMI 
6000B; Leica) and a charge-coupled device camera (DFC360FX; Leica) 
with a temperature-controlled stage.
For injection into Xenopus oocyte, ovary fragments were surgically 
removed from PMSG-primed Xenopus, and defolliculated oocytes were iso-
lated after treatment with 2.5 mg/ml collagenase in MBS buffer (10 mM 
Hepes, pH 7.4, 88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, and 2.4 mM 
Na2 HCO3) for 1–1.5 h. Stage VI oocytes were selected for all experiments. 
The indicated amounts of mRNAs, MO, or H2O were injected with a micro-
manipulator (Narishige USA) into defolliculated stage VI Xenopus oocytes. 
16 h after the injections, oocyte maturation was induced by stimulation with 
500 nM progesterone, and maturation was scored by the appearance of a 
white spot on the animal pole.
Immunofluorescence analysis
Oocytes were fixed in 4% paraformaldehyde in PBS for 1 h at room temper-
ature and permeabilized for 15 min in 0.1% Triton X-100 in PBS at room 
temperature. Oocytes were stained with anti–mouse lamin A antibody 
(Abcam) overnight at 4°C. After washing three times with PBS containing 
1 mg/ml BSA, the oocytes were incubated for 1 h with Alexa Fluor 594 
(Invitrogen). Oocytes were observed and imaged on the DMI 4000B 
inverted microscope.
Injection of MOs in mouse oocytes
For targeted knockdown of Wee1A, Wee1B, and Myt1, antisense MOs 
were purchased from Gene Tools, LLC. Sequences were as follows; Wee1A 
MO, 5-GCTGTCGGCTCAGGAAGCTCATTTC-3; Wee1B MO, 5-CTGGTC-
AGTCTCTGTGTCGGCCATC-3; and Myt1 MO, 5-CCTCGGTGGGCATGG-
TCATGGCAAC-3. The standard control MO with the sequence 5-CCTCTTA-
CCTCAGTTACAATTTATA-3 (Gene Tools, LLC) was used for control injections. 
All MOs were dissolved in nuclease-free water at a concentration of 1 mM 
and heated at 65°C for 5 min before injection. Oocytes were microinjected 
with 10 pl of the MO solutions. After injection, oocytes were transferred to 
M16 medium supplemented with 4 mg/ml BSA and 1 µM cilostamide and 
incubated at 37°C in 5% CO2 for 22 h, and GVBD was scored with a DMI 
4000B inverted microscope fitted with a Hoffman contrast lens.
Immunoprecipitation
Transient transfection with HA-Crm1 and various GFP-Wee1B mutants was 
performed using Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. After 48 h, cells were lysed in lysis buffer and 
homogenized. Cell lysates were incubated with anti-HA antibody and 
protein A–Sepharose beads (GE Healthcare). The precipitates were then 
washed with lysis buffer. The proteins were separated by SDS-PAGE, trans-
ferred to a polyvinylidene fluoride membrane, and analyzed by immuno-
blotting with V5 or HA antibodies.
Statistical analysis
Data are representative of at least three independent experiments, unless 
otherwise specified. Values were analyzed by one-way analysis of variance 
or Student’s t test, and P < 0.05 was considered statistically significant.
Online supplemental material
Fig. S1 shows the specificity and efficacy of MOs. Fig. S2 shows the sub-
cellular localization of Wee1B and Myt1. Fig. S3 shows the time course of 
nucleocytoplasmic shuttling of Wee1B and Cdc25B. Video 1 shows a time-lapse 
image of RFP-Cdc25B– and GFP-Wee1B–coinjected oocytes during meiotic 
resumption. Videos 2 and 3 show time-lapse images of RFP-Cdc25B and GFP-
Wee1B, respectively, during meiotic resumption. Online supplemental material 
is available at http://www.jcb.org/cgi/content/full/jcb.200907161/DC1.
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